• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于生物信息学分析鉴定非吸烟女性非小细胞肺癌中的潜在治疗靶点基因及机制

Identification of potential therapeutic target genes and mechanisms in non-small-cell lung carcinoma in non-smoking women based on bioinformatics analysis.

作者信息

Zhou W, Yin M, Cui H, Wang N, Zhao L-L, Yuan L-Z, Yang X-P, Ding X-M, Men F-Z, Ma X, Na J-R

机构信息

Department of Respiration, General Hospital of Ningxia Medical University, Yinchuan, China.

出版信息

Eur Rev Med Pharmacol Sci. 2015 Sep;19(18):3375-84.

PMID:26439031
Abstract

OBJECTIVE

The study was aimed to explore the underlying mechanisms and identify the potential target genes by bioinformatics analysis for non-small-cell lung carcinoma (NSCLC) treatment in non-smoking women.

MATERIALS AND METHODS

The microarray data of GSE19804 was downloaded from Gene Expression Omnibus (GEO) database. Paired samples (from the same patient) of tumor and normal lung tissues from 60 non-smoking female NSCLC patients were used to identify differentially expressed genes (DEGs). The functional enrichment analysis was performed. Furthermore, the protein-protein interaction (PPI) network of the DEGs was constructed by Cytoscape software. The module analysis was performed.

RESULTS

Totally, 817 DEGs including 273 up- and 544 down-regulated genes were identified. The up-regulated genes were mainly enriched in extracellular matrix (ECM)-receptor interaction, focal adhesion and cell cycle functions, while down-regulated genes were mainly enriched in the cytokine-cytokine receptor interaction pathway. DEGs including hyaluronan-mediated motility receptor (HMMR), collagen, type I alpha 2 (COL1A2), cyclin A2 (CCNA2), MAD2 mitotic arrest deficient-like 1 (MAD2L1), interleukin 6 (IL6) and interleukin 1, beta (IL1B) were identified in these functions. These genes were hub nodes in PPI networks. Besides, there were 3 up-regulated modules and 1 down-regulated module. The significant pathways were ECM-receptor interaction and focal adhesion in up-regulated modules, while in down-regulated module, the significant pathway was mitogen-activated protein kinase (MAPK) signaling pathway.

CONCLUSIONS

The ECM-receptor interaction, focal adhesion, cell cycle and cytokine-cytokine receptor interaction functions may be associated with NSCLC development. Genes such as HMMR, COL1A2, CCNA2, MAD2L1, IL6 and IL1B may be potential therapeutic target genes for NSCLC.

摘要

目的

本研究旨在通过生物信息学分析探索非小细胞肺癌(NSCLC)在不吸烟女性中的潜在发病机制并确定潜在靶基因,用于NSCLC治疗。

材料与方法

从基因表达综合数据库(GEO)下载GSE19804的微阵列数据。使用60例不吸烟女性NSCLC患者的肿瘤和正常肺组织配对样本(来自同一患者)来鉴定差异表达基因(DEG)。进行功能富集分析。此外,通过Cytoscape软件构建DEG的蛋白质-蛋白质相互作用(PPI)网络。进行模块分析。

结果

共鉴定出817个DEG,其中包括273个上调基因和544个下调基因。上调基因主要富集于细胞外基质(ECM)-受体相互作用、粘着斑和细胞周期功能,而下调基因主要富集于细胞因子-细胞因子受体相互作用途径。在这些功能中鉴定出包括透明质酸介导的运动受体(HMMR)、I型胶原蛋白α2(COL1A2)、细胞周期蛋白A2(CCNA2)、MAD2有丝分裂阻滞缺陷样1(MAD2L1)、白细胞介素6(IL6)和白细胞介素1β(IL1B)在内的DEG。这些基因是PPI网络中的枢纽节点。此外,有3个上调模块和1个下调模块。上调模块中的显著途径是ECM-受体相互作用和粘着斑,而下调模块中的显著途径是丝裂原活化蛋白激酶(MAPK)信号通路。

结论

ECM-受体相互作用、粘着斑、细胞周期和细胞因子-细胞因子受体相互作用功能可能与NSCLC的发生发展相关。HMMR、COL1A2、CCNA2、MAD2L1、IL6和IL1B等基因可能是NSCLC潜在的治疗靶基因。

相似文献

1
Identification of potential therapeutic target genes and mechanisms in non-small-cell lung carcinoma in non-smoking women based on bioinformatics analysis.基于生物信息学分析鉴定非吸烟女性非小细胞肺癌中的潜在治疗靶点基因及机制
Eur Rev Med Pharmacol Sci. 2015 Sep;19(18):3375-84.
2
The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.通过高通量数据的生物信息学分析鉴定肝细胞癌中的关键基因和信号通路。
Med Oncol. 2017 Jun;34(6):101. doi: 10.1007/s12032-017-0963-9. Epub 2017 Apr 21.
3
Investigation of Potential Mechanisms Associated with Non-small Cell Lung Cancer.非小细胞肺癌相关潜在机制的研究。
J Comput Biol. 2020 Sep;27(9):1433-1442. doi: 10.1089/cmb.2019.0081. Epub 2020 Feb 12.
4
Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.非小细胞肺癌诊断和预后的关键生物标志物的鉴定和综合分析。
Med Sci Monit. 2019 Dec 5;25:9280-9289. doi: 10.12659/MSM.918620.
5
Identification of potential therapeutic target genes, key miRNAs and mechanisms in acute myeloid leukemia based on bioinformatics analysis.基于生物信息学分析鉴定急性髓系白血病潜在治疗靶点基因、关键微小RNA及机制
Med Oncol. 2015 May;32(5):152. doi: 10.1007/s12032-015-0572-4. Epub 2015 Apr 2.
6
Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.基于综合生物信息学分析鉴定间变性甲状腺癌的关键通路和基因。
Med Sci Monit. 2018 Sep 14;24:6438-6448. doi: 10.12659/MSM.910088.
7
Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.通过生物信息学分析对非小细胞肺癌进行靶基因筛选及预后价值评估
Gene. 2018 Mar 20;647:306-311. doi: 10.1016/j.gene.2018.01.003. Epub 2018 Jan 3.
8
Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.通过生物信息学分析鉴定与 SCLC 相关的候选生物标志物和途径。
Mol Med Rep. 2018 Aug;18(2):1538-1550. doi: 10.3892/mmr.2018.9095. Epub 2018 May 29.
9
Identification of genes associated with lung cancer by bioinformatics analysis.通过生物信息学分析鉴定与肺癌相关的基因。
Eur Rev Med Pharmacol Sci. 2017 May;21(10):2397-2404.
10
Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.通过对微阵列数据的生物信息学分析揭示胶质瘤和神经胶质瘤发病机制的分子机制。
Med Oncol. 2017 Sep 26;34(11):182. doi: 10.1007/s12032-017-1043-x.

引用本文的文献

1
Screening of Immune-related lncRNAs in Lung Adenocarcinoma and Establishing a Survival Prognostic Risk Prediction Model.肺腺癌免疫相关 lncRNAs 的筛选及生存预后风险预测模型的建立。
Comb Chem High Throughput Screen. 2024;27(8):1175-1190. doi: 10.2174/1386207326666230913120523.
2
High Expression of , , and Predicts Worse Prognosis among Nonsmoking Patients with Lung Adenocarcinoma through Bioinformatics Analysis.通过生物信息学分析, 、 、 在不吸烟肺腺癌患者中的高表达预示着更差的预后。
Biomed Res Int. 2020 Oct 20;2020:2071593. doi: 10.1155/2020/2071593. eCollection 2020.
3
prediction and validation of potential therapeutic genes in pancreatic β-cells associated with type 2 diabetes.
2型糖尿病相关胰腺β细胞中潜在治疗基因的预测与验证
Exp Ther Med. 2020 Nov;20(5):60. doi: 10.3892/etm.2020.9188. Epub 2020 Sep 4.
4
Identification of key genes associated with progression and prognosis for lung squamous cell carcinoma.肺鳞状细胞癌进展和预后相关关键基因的鉴定
PeerJ. 2020 May 6;8:e9086. doi: 10.7717/peerj.9086. eCollection 2020.
5
A Novel Scoring System for Risk Assessment of Elderly Patients With Cytogenetically Normal Acute Myeloid Leukemia Based on Expression of Three AQP1 DNA Methylation-Associated Genes.一种基于三个水通道蛋白1(AQP1)DNA甲基化相关基因表达的老年细胞遗传学正常急性髓系白血病患者风险评估新评分系统
Front Oncol. 2020 Apr 21;10:566. doi: 10.3389/fonc.2020.00566. eCollection 2020.
6
Toll-like receptor 4 () deficiency aggravates dextran sulfate sodium (DSS)-induced intestinal injury by down-regulating , and .Toll样受体4()缺陷通过下调、和加重硫酸葡聚糖钠(DSS)诱导的肠道损伤。
Ann Transl Med. 2019 Dec;7(23):713. doi: 10.21037/atm.2019.12.28.
7
Genomic analyses based on pulmonary adenocarcinoma in situ reveal early lung cancer signature.基于原位肺腺癌的基因组分析揭示了早期肺癌特征。
BMC Med Genomics. 2018 Nov 20;11(Suppl 5):106. doi: 10.1186/s12920-018-0413-3.
8
A network-based signature to predict the survival of non-smoking lung adenocarcinoma.一种基于网络的特征用于预测非吸烟肺腺癌患者的生存情况。
Cancer Manag Res. 2018 Aug 16;10:2683-2693. doi: 10.2147/CMAR.S163918. eCollection 2018.